Synergy Pharmaceuticals Inc, a developer of gastrointestinal therapies, filed for bankruptcy on Wednesday with a deal to be acquired by Canadian health products maker Bausch Health Companies Inc for ...
Synergy CHC (NASDAQ:SNYR) filed to sell 1.28 million shares of common stock. This prospectus is not an offer to sell these securities. Filing Synergy CHC secures retail deals with McKesson Canada and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results